Applied Therapeutics (APLT) Earnings Date, Estimates & Call Transcripts $9.01 +0.09 (+1.01%) (As of 11/14/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Applied Therapeutics Latest Earnings SummaryUpcoming Q3 Earnings DateMar. 5EstimatedActual EPS (Aug. 7) -$0.13 Missed By -$0.03 Consensus EPS (Aug. 7) -$0.10 Applied Therapeutics posted Q2 2024 earnings on August 7, 2024, reporting an EPS of -$0.13, which missed analysts' consensus estimates of -$0.10 by $0.03. Quarterly revenue was reported to be $0.14 million, below analysts' expectations of $10 million. With a trailing EPS of -$1.61, Applied Therapeutics' earnings are expected to grow next year, from ($0.55) to ($0.48) per share. APLT Upcoming EarningsApplied Therapeutics' next earnings date is estimated for Wednesday, March 5, 2025, based off prior year's reporting schedules. Get Applied Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Applied Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAPLT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.APLT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Applied Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.07-$0.07-$0.07Q2 20242-$0.15-$0.11-$0.13Q3 20242-$0.14-$0.11-$0.13Q4 20242-$0.14-$0.11-$0.13FY 20247-$0.50-$0.40-$0.45Q1 20252-$0.12$0.06-$0.03Q2 20252-$0.14-$0.11-$0.13Q3 20252-$0.14-$0.08-$0.11Q4 20252-$0.14-$0.06-$0.10FY 20258($0.54)($0.19)($0.37) Applied Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/5/2025(Estimated)------- 8/7/2024Q2 2024-$0.10-$0.13 -$0.03-$0.13$10.00M$0.14M5/9/2024Q1 2024-$0.07-$0.16 -$0.09$0.35$10.00M$0.19M 3/6/2024Q4 2023-$0.15-$0.33 -$0.18-$0.33--$0.67M 11/9/2023Q3 2023--$0.47 -$0.47-$0.47-- 8/10/2023Q2 2023--$0.37 -$0.37-$0.37-- 5/11/2023Q1 2023--$0.18 -$0.18-$0.18-$10.66M Get the Latest News and Ratings for APLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/23/2023Q4 2022--$0.16 -$0.16-$0.16-- Applied Therapeutics Earnings - Frequently Asked Questions When is Applied Therapeutics's earnings date? Applied Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates. Learn more on APLT's earnings history. Did Applied Therapeutics beat their earnings estimates last quarter? In the previous quarter, Applied Therapeutics (NASDAQ:APLT) missed the analysts' consensus estimate of ($0.10) by $0.03 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. APLT's actual earnings. How much revenue does Applied Therapeutics generate each year? Applied Therapeutics (NASDAQ:APLT) has a recorded annual revenue of $-333,000.00. How much profit does Applied Therapeutics generate each year? Applied Therapeutics (NASDAQ:APLT) has a recorded net income of -$119.76 million. APLT has generated -$1.61 earnings per share over the last four quarters. What is Applied Therapeutics's EPS forecast for next year? Applied Therapeutics's earnings are expected to grow from ($0.55) per share to ($0.48) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Prothena Earnings Date Avid Bioservices Earnings Date Dynavax Technologies Earnings Date G1 Therapeutics Earnings Date Rigel Pharmaceuticals Earnings Date Puma Biotechnology Earnings Date ADMA Biologics Earnings Date Organon & Co. Earnings Date TG Therapeutics Earnings Date ImmunityBio Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. This page (NASDAQ:APLT) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
